🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/10/2007 | 50,77 | 51,49 | 50,65 | 51,17 | +0,90% | 1,65% | 6.659.516 |
| 08/10/2007 | 51,06 | 51,13 | 50,38 | 50,72 | -0,67% | 1,46% | 4.206.567 |
| 05/10/2007 | 50,76 | 51,56 | 50,73 | 51,06 | +1,23% | 1,64% | 9.296.074 |
| 04/10/2007 | 49,25 | 50,68 | 49,25 | 50,44 | +1,36% | 2,91% | 10.116.239 |
| 03/10/2007 | 49,22 | 50,31 | 49,08 | 49,76 | +1,03% | 2,48% | 8.664.759 |
| 02/10/2007 | 50,17 | 50,31 | 49,15 | 49,26 | -1,54% | 2,32% | 11.491.215 |
| 01/10/2007 | 49,62 | 50,28 | 49,43 | 50,03 | +1,43% | 1,71% | 11.636.887 |
| 28/09/2007 | 49,38 | 49,62 | 48,90 | 49,32 | -1,17% | 1,45% | 13.304.570 |
| 27/09/2007 | 50,11 | 50,22 | 49,54 | 49,90 | -0,57% | 1,35% | 7.114.558 |
| 26/09/2007 | 50,08 | 50,41 | 49,87 | 50,19 | +0,61% | 1,09% | 11.081.447 |
| 25/09/2007 | 49,31 | 50,20 | 49,17 | 49,89 | +1,16% | 2,09% | 11.139.402 |
| 24/09/2007 | 49,49 | 49,69 | 49,19 | 49,31 | -0,27% | 1,02% | 8.625.983 |
| 21/09/2007 | 49,06 | 49,69 | 49,03 | 49,45 | +0,86% | 1,36% | 14.918.385 |
| 20/09/2007 | 49,14 | 49,75 | 48,86 | 49,03 | -0,35% | 1,81% | 9.903.495 |
| 19/09/2007 | 48,50 | 49,36 | 47,82 | 49,20 | +1,96% | 3,17% | 12.927.290 |
| 18/09/2007 | 46,56 | 48,47 | 46,56 | 48,25 | +2,35% | 4,10% | 10.200.289 |
| 17/09/2007 | 46,99 | 47,38 | 46,73 | 47,15 | -0,26% | 1,38% | 7.201.646 |
| 14/09/2007 | 47,46 | 47,61 | 46,92 | 47,27 | -0,64% | 1,45% | 7.623.676 |
| 13/09/2007 | 48,19 | 48,55 | 47,34 | 47,58 | +0,38% | 2,51% | 12.863.047 |
| 12/09/2007 | 47,46 | 47,80 | 46,93 | 47,40 | -0,56% | 1,83% | 11.917.437 |
| 11/09/2007 | 47,81 | 47,93 | 47,24 | 47,66 | +0,28% | 1,44% | 8.005.986 |
| 10/09/2007 | 47,67 | 47,71 | 47,08 | 47,53 | +0,48% | 1,32% | 9.319.026 |
| 07/09/2007 | 47,90 | 48,57 | 47,19 | 47,30 | -1,78% | 2,89% | 12.171.891 |
| 06/09/2007 | 47,14 | 48,35 | 47,04 | 48,16 | +2,17% | 2,77% | 13.023.496 |
| 05/09/2007 | 47,27 | 47,42 | 46,78 | 47,14 | -1,28% | 1,35% | 8.506.616 |
| 04/09/2007 | 48,18 | 48,18 | 47,36 | 47,75 | -0,26% | 1,70% | 10.004.418 |
| 31/08/2007 | 47,75 | 48,19 | 47,61 | 47,87 | +1,03% | 1,22% | 7.681.002 |
| 30/08/2007 | 47,17 | 47,80 | 47,00 | 47,39 | -0,52% | 1,68% | 7.698.818 |
| 29/08/2007 | 46,97 | 47,71 | 46,50 | 47,63 | +1,44% | 2,58% | 6.599.046 |
| 28/08/2007 | 47,55 | 47,80 | 46,86 | 46,96 | -1,82% | 1,97% | 8.198.294 |